RxDoctor Payments Data

Carol Akerman, DPM

Foot Surgery · Knoxville, TNNPI 1720039779

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.0% of the total across 133 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Smith+Nephew at 24.4% of the total. Reporting peaked in 2023 at $1,830 and has fallen 66.3% since, to $617 in 2025.

$5,735in general payments, 2019–2025

Across 133 payments — averaging $43.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$1K
  • Paratek Pharmaceuticals, Inc.$620
  • Medtronic$591
  • Stryker$589
  • Triad Life Sciences Inc.$568
  • Nevro Corp.$336
  • plus $2K from 17 others

What the payments were for

  • Food & beverage$5,56297%
  • Education$1733%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,735 in reported general payments places this provider in the 80th percentile of 23 foot surgery providers in Tennessee.

See all foot surgery providers in Tennessee

Medicare billing

Part B allowed, 2024
$161,758
Medicare patients
489
Services billed
7,448

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Itraconazole12$2,592
Lidocaine-PrilocaineLidocaine/Prilocaine11$1,681
Cephalexin183$1,384
Gabapentin93$1,162
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen116$774
Terbinafine Hcl45$750
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim63$358
Ibuprofen18$352
Ciclopirox11$344
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav22$288
Nystatin12$266
Pregabalin20$226
Allopurinol23$208
Meloxicam59$150
Azithromycin12$147

Paid to pharmacies, not to this prescriber.

Other foot surgery in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →